Effect of Colchicine on Platelet-Platelet and Platelet-Leukocyte Interactions: a Pilot Study in Healthy Subjects

详细信息    查看全文

• 作者：Binita Shah ; Nicole Allen ; Bhisham Harchandani ; Michael Pillinger…
• 关键词：colchicine ; platelet aggregation ; neutrophil ; monocyte ; tissue adhesion
• 刊名：Inflammation
• 出版年：2016
• 出版时间：February 2016
• 年：2016
• 卷：39
• 期：1
• 页码：182-189
• 全文大小：2,007 KB
• 参考文献：1.Slobodnick A, Shah B, Pillinger MH, Krasnokutsky S. 2014. Colchicine: old and new. Am J Med.
  2.Crittenden, D.B., R.A. Lehmann, L. Schneck, R.T. Keenan, B. Shah, J.D. Greenberg, B.N. Cronstein, S.P. Sedlis, and M.H. Pillinger. 2012. Colchicine use is associated with decreased prevalence of myocardial infarction in patients with gout. Journal of Rheumatology 39: 1458–1464.PubMedCentral CrossRef PubMed
  3.Nidorf, S.M., J.W. Eikelboom, C.A. Budgeon, and P.L. Thompson. 2013. Low-dose colchicine for secondary prevention of cardiovascular disease. Journal of the American College of Cardiology 61: 404–410.CrossRef PubMed
  4.Menche, D., A. Israel, and S. Karpatkin. 1980. Platelets and microtubules. Effect of colchicine and D2O on platelet aggregation and release induced by calcium ionophore A23187. Journal of Clinical Investigation 66: 284–291.PubMedCentral CrossRef PubMed
  5.Behnke, O. 1965. Further studies on microtubules. A marginal bundle in human and rat thrombocytes. Journal of Ultrastructure Research 13: 469–477.CrossRef PubMed
  6.White, J.G. 1968. Fine structural alterations induced in platelets by adenosine diphosphate. Blood 31: 604–622.PubMed
  7.White, J.G. 1968. Effects of colchicine and Vinca alkaloids on human platelets. I. Influence on platelet microtubules and contractile function. American Journal of Pathology 53: 281–291.PubMedCentral PubMed
  8.White, J.G. 1969. Effects of colchicine and vinca alkaloids on human platelets. 3. Influence on primary internal contraction and secondary aggregation. American Journal of Pathology 54: 467–478.PubMedCentral PubMed
  9.Terkeltaub, R.A., D.E. Furst, K. Bennett, K.A. Kook, R.S. Crockett, and M.W. Davis. 2010. High versus low dosing of oral colchicine for early acute gout flare. Arthritis and Rheumatism 62: 1060–1068.CrossRef PubMed
  10.Merolla, M., M.A. Nardi, and J.S. Berger. 2012. Centrifugation speed affects light transmission aggregometry. International Journal of Laboratory Hematology 34: 81–85.PubMedCentral CrossRef PubMed
  11.Furman, M.I., S.E. Benoit, M.R. Barnard, C.R. Valeri, M.L. Borbone, R.C. Becker, H.B. Hechtman, and A.D. Michelson. 1998. Increased platelet reactivity and circulating monocyte‐platelet aggregates in patients with stable coronary artery disease. Journal of the American College of Cardiology 31: 352–358.CrossRef PubMed
  12.Shah, B., S.P. Sedlis, X. Mai, N.S. Amoroso, Y. Guo, J.D. Lorin, and J.S. Berger. 2013. Comparison of platelet activity measurements using arterial and venous blood sampling. Journal of Thrombosis and Haemostasis 11: 1922–1924.PubMedCentral PubMed
  13.Shah, B., V. Valdes, M.A. Nardi, L. Hu, E. Schrem, and J.S. Berger. 2014. Mean platelet volume reproducibility and association with platelet activity and anti-platelet therapy. Platelets 25: 188–192.PubMedCentral CrossRef PubMed
  14.Bouaziz, A., N.B. Amor, G.E. Woodard, H. Zibidi, J.J. Lopez, A. Bartegi, G.M. Salido, and J.A. Rosado. 2007. Tyrosine phosphorylation/dephosphorylation balance is involved in thrombin-evoked microtubular reorganization in human platelets. Thrombosis and Haemostasis 98: 375–384.PubMed
  15.Wittels, E., A. Israel, and S. Karpatkin. 1981. Evidence for colchicine-dependent protease activity in human platelets. Thrombosis Research 24: 215–221.CrossRef PubMed
  16.Raju, N.C., Q. Yi, M. Nidorf, N.D. Fagel, R. Hiralal, and J.W. Eikelboom. 2012. Effect of colchicine compared with placebo on high sensitivity C-reactive protein in patients with acute coronary syndrome or acute stroke: a pilot randomized controlled trial. Journal of Thrombosis and Thrombolysis 33: 88–94.CrossRef PubMed
  17.Abanonu, G.B., A. Daskin, M.F. Akdogan, S. Uyar, and R. Demirunc. 2012. Mean platelet volume and B-thromboglobulin levels in familial Mediterranean fever: effect of colchicine use? European Journal of Internal Medicine 23: 661–664.CrossRef PubMed
  18.Cronstein, B.N., Y. Molad, J. Reibman, E. Balakhane, R.I. Levin, and G. Weissmann. 1995. Colchicine alters the quantitative and qualitative display of selectins on endothelial cells and neutrophils. Journal of Clinical Investigation 96: 994–1002.PubMedCentral CrossRef PubMed
  19.Roberge, C.J., M. Gaudry, R. de Médicis, A. Lussier, P.E. Poubelle, and P.H. Naccache. 1993. Crystal-induced neutrophil activation. IV. Specific inhibition of tyrosine phosphorylation by colchicine. Journal of Clinical Investigation 92: 1722–1729.PubMedCentral CrossRef PubMed
  20.Martinon, F., V. Pétrilli, A. Mayor, A. Tardivel, and J. Tschopp. 2006. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440: 237–241.CrossRef PubMed
  21.Furman, M.I., M.R. Barnard, L.A. Krueger, M.L. Fox, E.A. Shilale, D.M. Lessard, P. Marchese, A.L. Frelinger 3rd, R.J. Goldberg, and A.D. Michelson. 2001. Circulating monocyte‐platelet aggregates are an early marker of acute myocardial infarction. Journal of the American College of Cardiology 38: 1002–1006.CrossRef PubMed
  22.Mickelson, J.K., N.M. Lakkis, G. Villarreal‐Levy, B.J. Hughes, and C.W. Smith. 1996. Leukocyte activation with platelet adhesion after coronary angioplasty: a mechanism for recurrent disease? Journal of the American College of Cardiology 28: 345–353.CrossRef PubMed
  23.Hayward, R., B. Campbell, Y.K. Shin, R. Scalia, and A.M. Lefer. 1999. Recombinant soluble p‐selectin glycoprotein ligand‐1 protects against myocardial ischemic reperfusion injury in cats. Cardiovascular Research 41: 65–76.CrossRef PubMed
  24.Cercedo, D., R. Stock, S. Gonzalez, E. Reyes, and R. Mondragon. 2002. Modification of actin, myosin and tubulin distribution during cytoplasmic granule movements associated with platelet adhesion. Haematologica 87: 1165–1176.
  
• 作者单位：Binita Shah (1) (2)
  Nicole Allen (1)
  Bhisham Harchandani (1)
  Michael Pillinger (3)
  Stuart Katz (1)
  Steven P. Sedlis (1) (2)
  Christina Echagarruga (1)
  Svetlana Krasnokutsky Samuels (3)
  Pajazit Morina (1)
  Prabhjot Singh (1)
  Liza Karotkin (1)
  Jeffrey S. Berger (4)
  
  1. Department of Medicine, Division of Cardiology, New York University School of Medicine, 227 E 30th Street, Office 835, New York, NY, 10016, USA
  2. Department of Medicine, Section of Cardiology, Veterans Affairs New York Harbor Health Care System, New York, NY, USA
  3. Department of Medicine, Division of Rheumatology, New York University School of Medicine, New York, NY, USA
  4. Department of Medicine, Divisions of Cardiology and Hematology, New York University School of Medicine, New York, NY, USA
  
• 刊物类别：Medicine
• 刊物主题：Medicine & Public Health
  Rheumatology
  Internal Medicine
  Pharmacology and Toxicology
  Pathology
  
• 出版者：Springer Netherlands
• ISSN：1573-2576

文摘

The cardioprotective mechanisms of colchicine in patients with stable ischemic heart disease remain uncertain. We tested varying concentrations of colchicine on platelet activity in vitro and a clinically relevant 1.8-mg oral loading dose administered over 1 h in 10 healthy subjects. Data are shown as median [interquartile range]. Colchicine addition in vitro decreased light transmission platelet aggregation only at supratherapeutic concentrations but decreased monocyte- (MPA) and neutrophil-platelet aggregation (NPA) at therapeutic concentrations. Administration of 1.8 mg colchicine to healthy subjects had no significant effect on light transmission platelet aggregation but decreased the extent of MPA (28 % [22–57] to 22 % [19–31], p = 0.05) and NPA (19 % [16–59] to 15 % [11–30], p = 0.01), platelet surface expression of PAC-1 (370 mean fluorescence intensity (MFI) [328–555] to 333 MFI [232–407], p = 0.02) and P-selectin (351 MFI [269–492] to 279 [226–364], p = 0.03), and platelet adhesion to collagen (10.2 % [2.5–32.6] to 2.0 % [0.2–9.5], p = 0.09) 2 h post-administration. Thus, in clinically relevant concentrations, colchicine decreases expression of surface markers of platelet activity and inhibits leukocyte-platelet aggregation but does not inhibit homotypic platelet aggregation. KEY WORDS colchicine platelet aggregation neutrophil monocyte tissue adhesion